Clinical efficacy and safety of HER2 targeted therapy in patients with metastatic colorectal cancer: A systematic review and meta-analysis
The locations of the cell bodies of neurons recorded in the IML were confirmed after staining with NeuroTrace (435/455 blue or 530/615 red fluorescence, Invitrogen)
Most patients begin experiencing initial improvements in sleep and energy within the first month, with significant body composition changes becoming evident after three to six months of consistent therapy under medical supervision
Other markers including lipid profiles and inflammatory markers may improve as body composition optimizes
[DOI] [PMC free article] [PubMed] [Google Scholar] 44.Tolmunen T., Voutilainen S., Hintikka J., Rissanen T., Tanskanen A., Viinamki H., Kaplan G.A., Salonen J.T